XV SDDN meeting 2023, Barcelona
On November 20th and 21st, some members of the Welab’s team attended the XV Spanish Drug Discovery Network (SDDN) meeting,…
A new JMedChem publication from...
Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties”, in the Journal of Medicinal…
Fundación MEDINA and WeLab Barcelona
Fundación Medina and WeLab Barcelona have signed a collaboration agreement that allows combining experience and resources for the discovery and…
New Sigma-1 receptor-BiP biosensor
Scientists from the Pathology and Experimental Therapeutics Dept., Facultat de Medicina i Ciències de la Salut of the Universitat de…
Taros – Welab collaboration agreement
We are proud to announce that Welab Barcelona, the drug discovery & development platform of Leitat, has signed a strategic…
Pharmacelera-Welab partnership agreement
Pharmacelera, the leading provider of computational tools for hit discovery, and Welab, the leading drug discovery and development platform is…
Where does our logo come...
https://www.welabbarcelona.com/wp-content/uploads/2023/06/Welab-logo.mp4
Spirify – Welab Barcelona research...
WeLab Barcelona has reached an agreement with Spirify Pharma for a research collaboration on characterization of Spirify’s proprietary analogs of…
Carcinogenicity studies of cizolirtine, a...
Check out the new Welab’s publication on toxicological profile of cizolirtine. Results from two-year rodent oral carcinogenicity studies of cizolirtine,…
Comprehensive Preclinical Assessment of Sensory,...
Check out the recent Welab’s publication on alternative methods for pain assessment.Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical…
Pharmacological Probes to Validate Biomarkers...
Check out the IMI-PainCare project publication, with the contribution of WeLab Barcelona. Link to full text: https://lnkd.in/edsw_BJN“Biomarkers of nociceptive signal…
New publication in ACS Medicinal...
Check out the new Welab’s publication in the Virtual Special Issue from ACS Medicinal Chemistry Letters “Medicinal Chemistry in Portugal…
IMI-Paincare General Assembly
We have participated in the General Assembly of the IMI-PainCare consortium. An excellent opportunity for sharing results and ideas on…
Welab is GLP certified R&D...
Welab Barcelona has been certified by the competent authority as compliant with the Principles of Good Laboratory Practice (GLP). The…
Welab has signed an Agreement...
IMI-Paincare is the biggest European consortium in the pain field, including some of the more relevant research centers and pharmaceutical…
ESTEVE and LEITAT announce strategic...
An alliance to create WeLab, a bio incubator, accelerator hub and center of excellence for biomedicine & pharma in Spain.…